Advances in the diagnosis of neuromuscular junction disorders

American Journal of Physical Medicine and Rehabilitation

Volumn 84, Issue 8, 2005, Pages 627-638

  Meriggioli, Matthew N ^a   Sanders, Donald B ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acetylcholine Receptor Antibodies; Lambert Eaton Myasthenic Syndrome; Muscle Specific Receptor Tyrosine Kinase Antibodies; Myasthenia Gravis; Neuromuscular Junction; Repetitive Nerve Stimulation; Single Fiber Electromyography

Indexed keywords

ACETYLCHOLINESTERASE; ALPHA BUNGAROTOXIN; ATROPINE; AUTOANTIBODY; CALCIUM; CHOLINERGIC RECEPTOR ANTIBODY; CHOLINESTERASE INHIBITOR; CONNECTIN; EDROPHONIUM CHLORIDE; ENZYME ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MUSCLE ANTIBODY; MUSCLE ANTIGEN; MUSCLE PROTEIN; NEOSTIGMINE; NEOSTIGMINE METHYL SULFATE; PROTEIN ANTIBODY; PROTEIN TYROSINE KINASE; PYRIDOSTIGMINE; RYANODINE RECEPTOR; VOLTAGE GATED CALCIUM CHANNEL;

ABDOMINAL CRAMP; BOTULISM; BRADYCARDIA; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EATON LAMBERT SYNDROME; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; FASCICULATION; HUMAN; HYPERHIDROSIS; HYPERSALIVATION; HYPOTENSION; MUSCLE BIOPSY; MUSCLE STRENGTH; MYASTHENIA GRAVIS; NAUSEA; NERVE STIMULATION; NEUROMUSCULAR JUNCTION DISORDER; PRACTICE GUIDELINE; PROVOCATION TEST; REVIEW; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SYNCOPE;

BOTULISM; CHOLINESTERASE INHIBITORS; EDROPHONIUM; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; HUMANS; IMMUNOLOGIC TESTS; LAMBERT-EATON MYASTHENIC SYNDROME; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION DISEASES; SENSITIVITY AND SPECIFICITY;

EID: 22644432459     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.phm.0000171169.79816.4c     Document Type: Review

References (69)

1. Osserman KE, Kaplan LI: Rapid diagnostic test for myasthenia gravis. JAMA 1952;150:265-68
2. Katz B, Miledi R: The binding of acetylcholine to receptors and its removal from the synaptic cleft. J Physiol 1973;231: 549-74
3. Daroff RB: The office Tensilon test for ocular myasthenia gravis. Arch Neurol 1986;43:843-4
4. Ing EB, Ing SY, Ing T, et al: The complication rate of edrophonium testing for suspected myasthenia gravis. Can J Ophthalmol 2000;35:141-4
5. Pascuzzi RM: The edrophonium test. Semin Neurol 2003; 23:83-8
6. Mulder DW, Lambert EH, Eaton LM: Myasthenic syndrome in patients with ALS. Neurology 1959;9:627-31
7. Dirr LY, Donofrio PD, Patton JF, et al: A false-positive edrophonium test in a patient with a brainstem glioma. Neurology 1989;39:865-7
8. Mindel JS, Charney JZ: Bilateral intracavernous carotid aneurysms presenting as pseudoocular myasthenia gravis. Trans Am Ophthalmol Soc 1989;87:445-57
9. Diamond S, Shear HE, Leeds MF: Pseudointernuclear oculomotor ophthalmoplegia secondary to Guillain-Barré polyneuritis simulating myasthenia gravis in an air transport pilot. Aviat Space Environ Med 1975;46:204-7
10. Khan GA, Bank N: Interpretation of positive edrophonium (Tensilon) test in patients with end-stage renal disease. Ren Fail 1995;17:65-71
11. Osserman KE, Genkins G: Studies in myasthenia gravis: Review of a 20-year experience in over 1200 patients. Mt Sinai J Med 1971;38:497-537
12. Rowland LP: Prostigmine-responsiveness and the diagnosis of myasthenia gravis. Neurology 1955;5:612-24
13. Viets HR, Schwab RS: Prostigmine in the diagnosis of myasthenia gravis. N Engl J Med 1935;213:1280-3
14. Jolly F: Ueber myasthenia gravis pseudoparalytica. Berliner Klinische Wochenschrift 1895;32:1-7
15. Harvey AM, Masland RL: A method for the study of neuromuscular transmission in human subjects. Bull Johns Hopkins Hosp 1941;68:81-93
16. Kimura J: Principles of nerve conduction studies, in Kimura J (ed): Electrodiagnosis in Diseases of Nerve and Muscle. Philadelphia, FA Davis, 1989, pp 78-101
17. AAEM Quality Assurance Committee. American Association of Electrodiagnostic Medicine: Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnosis of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome. Muscle Nerve 2001;24:1239-47
18. Howard JF Jr, Sanders DB, Massey JM: The electrodiagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome. Neurol Clin 1994;12:305-30
19. Killian JM, Wilfong AA, Burnett L, et al: Decremental motor responses to repetitive nerve stimulation in ALS. Muscle Nerve 1994;17:747-54
20. Henderson RD, Daube JR: Decrement in surface-recorded motor unit action potentials in amyotrophic lateral sclerosis. Neurology 2004;63:1670-4
21. Eaton LM, Lambert EH: Electromyography and electric stimulation of nerves in diseases of the motor unit. JAMA 1957;163:1117-24
22. Lambert EH: Defects of neuromuscular transmission in syndromes other than myasthenia gravis. Ann N Y Acad Sci 1966;135:367-84
23. Lambert EH, Eaton LM, Rooke ED: Defect of neuromuscular conduction associated with malignant neoplasms. Am J Physiol 1956;187:612-3
24. Tim RW, Sanders DB: Repetitive nerve stimulation studies in the Lambert-Eaton myasthenic syndrome. Muscle Nerve 1994;17:995-1001
25. Tim RW, Massey JM, Sanders DB: Lambert-Eaton myasthenic syndrome (LEMS): Clinical and electrophysiologic features and response to therapy of 59 patients. Ann N Y Acad Sci 1998;841:823-6
26. Cherington M: Electrophysiologic methods as an aid in diagnosis of botulism: A review. Muscle Nerve 1982;5:528-9
27. Cornblath DR, Sladky JT, Sumner AJ: Clinical electrophysiology of infant botulism. Muscle Nerve 1983;6:448-52
28. Engel AG: The investigation of congenital myasthenic syndromes. Ann N Y Acad Sci 1993;681:425-34
29. Harper CM: Congenital myasthenic syndromes. Semin Neurol 2004;24:111-23
30. Stålberg EV, Trontelj JV: Single Fiber Electromyography: Studies in Healthy and Diseased Muscle, ed 2. New York, Raven Press, 1994
31. Single fiber EMG reference values: A collaborative effort. Ad Hoc Committee of the AAEM Special Interest Group on Single Fiber EMG. Muscle Nerve 1992;15:151-61
32. Oh SJ, Kim DE, Kuruoglu R, et al: Diagnostic sensitivity of the laboratory tests in myasthenia gravis. Muscle Nerve 1992;15:720-4
33. Sanders DB, Howard JF: AAEE minimonograph #25: Single-fiber electromyography in myasthenia gravis. Muscle Nerve 1986;9:809-19
34. Sanders DB, Howard JF, Johns TR: Single fiber electromyography in myasthenia gravis. Neurology 1979;29:68-76
35. Sanders DB, Stålberg EV: AAEM minimonograph #25: Single-fiber electromyography. Muscle Nerve 1996;19:1069-83
36. Sanders DB: The effect of firing rate on neuromuscular jitter in Lambert-Eaton myasthenic syndrome. Muscle Nerve 1992;15:256-8
37. Lindstrom J: An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin Immunol Immunopathol 1977;7:36-43
38. Lindstrom JM, Seybold ME, Lennon VA, et al: Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value. Neurology 1976; 26:1054-9
39. Vincent A, Newsom-Davis J: Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: Results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 1985;48:1246-52
40. Lennon VA: Serological diagnosis of myasthenia gravis and Lambert-Eaton myasthenic syndrome, in Lisak RP (ed): Handbook of Myasthenia Gravis and Myasthenic Syndromes. New York, Marcel Dekker, 1994, pp 149-64
41. Howard FM, Lennon V, Finley J, et al: Clinical correlations of antibodies that bind, block or modulate human acetylcholine receptors in myasthenia gravis. Ann N Y Acad Sci 1987;505:526-38
42. Drachman DB, Adams RN, Josefik LF, et al: Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 1982;307:769-75
43. Lennon VA: Serologic profile of myasthenia gravis and distinction from Lambert-Eaton myasthenic syndrome. Neurology 1997;48(suppl 5):S23-7
44. Husain AM, Massey JM, Howard JF, et al: Acetylcholine receptor antibody measurements in acquired myasthenia gravis. Ann N Y Acad Sci 1998;841:471-4
45. Strauss AJ, Seegal BC, Hsu KC, et al: Immunofluorescence demonstration of a muscle binding, complement fixing serum globulin fraction in myasthenia gravis. Proc Soc Exp Biol Med 1960;105:184-91
46. Cikes N, Momoi MY, Williams CL, et al: Striational autoantibodies: Quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of D-penicillamine or allogeneic bone marrow. Mayo Clin Proc 1988;63:474-81
47. Lennon VA, Howard FM: Serological diagnosis of myasthenia gravis, in Nakamura, M, O'Sullivan MB (eds): Clinical Laboratory Molecular Analysis: New Strategies in Autoimmunity, Cancer and Virology. New York, Grune and Stratton, 1985, 29-44
48. Gautel M, Lakey A, Barlow DP, et al: Titin antibodies in myasthenia gravis: Identification of a major immunogenic region of titin. Neurology 1993;43:1581-5
49. Skeie GO, Mygland A, Aarli JA, et al: Titin antibodies in patients with late onset myasthenia gravis: Clinical correlations. Autoimmunity 1995;20:99-104
50. Skeie GO, Lunde PK, Sejersted OM, et al: Autoimmunity against the ryanodine receptor in myasthenia gravis. Acta Physiol Scand 2001;171:379-84
51. Romi F, Skeie GO, Aarli JA, et al: Muscle autoantibodies in subgroups of myasthenia gravis patients. J Neurol 2000; 247:369-75
52. Evoli A, Tonali PA, Padua L, et al: Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003;126:2304-11
53. Hoch W, McConville J, Helms S, et al: Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001;7:365-8
54. McConville J, Farrugia ME, Beeson D, et al: Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 2004;55:580-4
55. Sanders DB, El-Salem K, Massey JM, et al: Clinical aspects of MuSK antibody positive seronegative MG. Neurology 2003;60:1978-80
56. Zhou L, McConville J, Chaudhry V, et al: Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients. Muscle Nerve 2004;30:55-60
57. Sanders DB, Vincent A, Massey JM: Electromyography in muscle specific tyrosine kinase positive seronegative myasthenia gravis. Muscle Nerve 2003;suppl 12:127
58. Motomura M, Johnston I, Lang B, et al: An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 1995;58:85-7
59. Lennon VA, Kryzer TJ, Griesmann GE, et al: Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332: 1467-74
60. Mason WP, Graus F, Lang B et al: Paraneoplastic cerebellar degeneration and small cell lung carcinoma. Brain 1997; 120:1279-1300
61. Trivedi R, Mundanthanan G, Amyes L, et al: Which antibodies are worth testing in subacute cerebellar ataxia? Lancet 2000;356:565-6
62. Czaplinski A, Steck AJ, Fuhr P: Ice pack test for myasthenia gravis: A simple, noninvasive and safe diagnostic method. J Neurol 2003;250:883-4
63. Kubis KC, Danesh-Meyer HV, Savino PJ, et al: The ice test versus rest test in myasthenia gravis. Ophthalmology 107: 1195-8
64. Sethi KD, Rivner MH, Swift TR: Ice pack test for myasthenia gravis. Neurology 1987;37:1383-5
65. Larner AJ: The place of the ice pack test in the diagnosis of myasthenia gravis. Int J Clin Pract 2004;58:887-8
66. Coers C, Telerman-Toppet N: Morphological and histochemical changes of motor units in myasthenia. Ann N Y Acad Sci 1976;274:6-19
67. Squier M, Chalk C, Hilton-Jones D, et al: Type 2 fiber predominance in Lambert-Eaton myasthenic syndrome. Muscle Nerve 1991;14:625-32
68. AAEM Quality Assurance Committee, American Association of Electrodiagnostic Medicine: Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: Summary statement. Muscle Nerve 2001;24:1236-8
69. Meriggioli MN: Diagnostic tests for neuromuscular junction disorders, in Meriggioli MN, Howard JF, Harper CM (eds): Neuromuscular Junction Disorders: Diagnosis and Treatment. New York, Marcel Dekker, 2003, pp 59-99